Publications

View by Year

2019 Publications

Defining the NSD2 interactome: PARP1 PARylation reduces NSD2 histone methyltransferase activity and impedes chromatin binding

Huang X, LeDuc RD, Fornelli L, Schunter AJ, Bennett RL, Kelleher NL, Licht JD.

J Biol chem, 294 (33), pp. 12459-12471, 2019.
10.1074/jbc.RA118.006159


A Mutation in Histone H2B Represents a New Class of Oncogenic Driver

Bennett RL, Bele A, Small EC, Will CM, Nabet B, Oyer JA, Huang X, Ghosh RP, Grzybowski AT, Yu T, Zhang Q, Riva A, Lele TP, Schatz GC, Kelleher NL, Ruthenburg AJ, Liphardt J, Licht JD.

Cancer Discovery, 9 (10), pp. 1438-1451, 2019.
10.1158/2159-8290


2018 Publications

An activating mutation of the NSD2 histone methyltransferase drives oncogenic reprogramming in acute lymphocytic leukemia.

Swaroop A, Oyer JA, Will CM, Huang X, Yu W, Troche C, Bulic M, Durham BH, Wen QJ, Crispino JD, MacKerell AD Jr, Bennett RL, Kelleher NL, Licht JD.

Oncogene, (), pp. , 2018.
10.1038/s41388-018-0474-y


2017 Publications

The Role of Nuclear Receptor–Binding SET Domain Family Histone Lysine Methyltransferases in Cancer

Bennett, RL; Swaroop, A; Troche, C; Licht, JD.

Cold Spring Harbor Perspectives in Medicine, (), pp. , 2017.
10.1101/cshperspect.a026708


2016 Publications

Post transcriptional control of the epigenetic stem cell regulator PLZF by sirtuin and HDAC deacetylases

McConnell, MJ; Durand, L; Langley, E; Coste-Sarguet, L; Zelent, A; Chomienne, C; Kouzarides, T; Licht, JD; Guidez, F.

Epigenetics & Chromatin, 24 (8), pp. 38, 2016.
10.1186/s13072-015-0030-8


Increased protein processing gene signature in HDACi-resistant cells predicts response to proteasome inhibitors

Dupéré-Richer, D; Kinal, M; Pettersson, F; Emond, A; Calvo-Vidal, MN; Nichol, JN; Guilbert, C; Plourde, D; Klein, Oros K; Nielsen, TH; Ezponda, T; Licht, JD; Johnson, NA; Assouline, S; Cerchietti, WH; Miller, Jr, WH; Mann, KK.

Leuk Lymphoma, 58 (1), pp. 218-221, 2016.
10.1080/10428194.2016.1180684


H3K27 Methylation: A Focal Point of Epigenetic Deregulation in Cancer

Nichol, JN; Dupéré-Richer, D; Ezponda, T; Licht, JD; Miller, Jr, WH.

Adv Cancer Res, 131 (0), pp. 59-95, 2016.
10.1016/bs.acr.2016.05.001


EZH2 and BCL6 Cooperate to Assemble CBX8-BCOR Complex to Repress Bivalent Promoters, Mediate Germinal Center Formation and Lymphomagenesis

Béguelin, W; Teater, M; Gearhart, MD; Fernández, MT Calvo; Goldstein, RL; Cárdenas, MG; Hatzi, K; Rosen, M; Shen, H; Corcoran, CM; Hamline, MY; Gascoyne, RD; Levine, RL; Abdel-Wahab, O; Licht, JD; Shaknovich, R; Elemento, O; Bardwell, VJ; Melnick, AM.

Cancer Cell, 30 (2), pp. 197-213, 2016.
10.1016/j.ccell.2016.07.006


Loss of Mll3 Catalytic Function Promotes Aberrant Myelopoiesis

Arcipowski, KM; Bulic, M; Gurbuxani, S; Licht, JD.

PLoS One, 11 (9), pp. e0162515, 2016.
10.1371/journal.pone.0162515


MMSET/WHSC1 enhances DNA damage repair leading to an increase in resistance to chemotherapeutic agents

Shah, MY; Martinez-Garcia, E; Phillip, JM; Chambliss, AB; Popovic, R; Ezponda, T; Small, EC; Will, C; Phillip, MP; Neri, P; Bahlis, NJ; Wirtz, D; Licht, JD.

Oncogene, 35 (45), pp. 5905-5915, 2016.
10.1038/onc.2016.116


Histone H1 and Chromosomal Protein HMGN2 Regulate Prolactin-Induced STAT5 Transcription Factor Recruitment and Function in Breast Cancer Cells

Schauwecker, SM; Kim, JJ; Licht, JD; Clevenger, CV.

J Biol Chem, (0), pp. , 2016.
10.1074/jbc.M116.764233


2015 Publications

Strong expression of EZH2 and accumulation of trimethylated H3K27 in diffuse large B-cell lymphoma independent of cell of origin and EZH2 codon 641 mutation

Zhou, Z; Gao, J; Popovic, R; Wolniak, K; Parimi; Winter, JN; Licht, JD; Chen, YH.

Leuk Lymphoma, 56 (10), pp. 2895-2901, 2015.
10.3109/10428194.2015.1006220


GLI2-dependent c-MYC upregulation mediates resistance of pancreatic cancer cells to the BET bromodomain inhibitor JQ1

Kumar, K; Raza, SS; Knab, LM; Chow, CR; Kwok, B; Bentrem, DJ; Popovic, R; Ebine, K; Licht, JD; Munshi, HG.

Sci Rep, 5 (0), pp. 9489, 2015.
10.1038/srep09489


Unabridged Analysis of Human Histone H3 by Differential Top-Down Mass Spectrometry Reveals Hypermethylated Proteoforms from MMSET/NSD2 Overexpression

Zheng, Y; Fornelli, L; Compton, PS, Sharma, S; Canterbury, J; Mullen, C; Zarbroushov, Fellers, RT; Thomas, PM; Licht, JD; Senko, MW; Kelleher, NL.

Mol Cell Proteomics, 15 (3), pp. 776-90, 2015.
10.1074/mcp.M115.053819


Deregulation of the Ras-Erk Signaling Axis Modulates the Enhancer Landscape

Nabet, B; Broin, PÓ; Reyes, JM; Shieh, K; Lin CY; Will, CM; Popovic, R; Ezponda, T; Bradner, JE; Golden, AA; Licht, JD.

Cell Rep, 12 (8), pp. 1300-1313, 2015.
10.1016/j.celrep.2015.06.078


DNA Methylation Inhibitors in Cancer Therapy: The Immunity Dimension

Licht, JD.

Cell, 162 (5), pp. 938-939, 2015.
10.1016/j.cell.2015.08.005


2014 Publications

From anecdote to targeted therapy: the curious case of thalidomide in multiple myeloma

Licht, JD; Shortt, J; Johnstone, R.

Cancer Cell, 25 (1), pp. 9-11, 2014.
10.1016/j.ccr.2013.12.019


Single-cell nucleosome mapping reveals the molecular basis of gene expression heterogeneity

Small, EC; Xi, L; Wang, JP; Widom, J; Licht, JD.

Proc Natl Acad Sci USA, 111 (24), pp. E2462-E2471, 2014.
10.1073/pnas.1400517111


Promyelocytic leukemia zinc finger-retinoic acid receptor α (PLZF-RARα), an oncogenic transcriptional repressor of cyclin-dependent kinase inhibitor 1A (p21WAF/CDKN1A) and tumor protein p53 (TP53) genes

Choi, WI; Yoon, JH; Kim, MY; Koh, DI; Licht, JD; Kim, K; Hur Choi, MW.

J Biol Chem, 289 (27), pp. 18641-18656, 2014.
10.1074/jbc.M113.538777


Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation

Popovic, R; Martinez-Garcia, E; Giannopoulou, EG; Zhang, Q; Ezponda, T; Shah, MY; Zheng, Y; Will, CM; Small, EC; Hua, Y; Bulic, M; Jiang, Y; Carrara, M; Calogero, RA; Kath, WL; Keller, NL; Wang, JP; Elemento, O; Licht, JD.

PLoS Genet, 10 (9), pp. e1004566, 2014.
10.1371/journal.pgen.1004566


Molecular pathways: deregulation of histone h3 lysine 27 methylation in cancer-different paths, same destination

Ezponda, T; Licht, JD.

Clin Cancer Res, 20 (19), pp. 5001-5008, 2014.
10.1158/1078-0432.CCR-13-2499


DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia

Rampal, R; Alkalin, A; Madzo, J; Vasanthakumar, A; Pronier, E; Patel, J; Li, Y; Ahn, J; Abdel-Wahab, O; Shih, A; Lu, C; Ward, PS; Tsai, JJ; Hricik, T; Tosello, V; Tallman, JE; Zhao, X; Daniels, D; Dai, Ciminio, L; Aifantis, I; He, C; Fuks, F; Tallman, MS; Ferrando, A; Nimer, S; Paietta, E; Thompson, CB; Licht, JD; Mason, CE; Godley, LA; Melnick, A; Figueroa, ME; Levine, RL.

Cell Rep, 9 (5), pp. 1841-55, 2014.
10.1016/j.celrep.2014.11.004